ACVRL1 and leukemia: HHT also targets the phosphorylated serine 209 residues of the eukaryotic translation initiation factor eIF4E, resulting in the degradation of the phosphorylated protein and hindering the growth of leukemia cells both in-vitro and in-vivo [13].